The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapy

BACKGROUND: Significant improvements in mortality among patients with non-small cell lung cancer (NSCLC) in the USA over the past two decades have been reported based on Surveillance, Epidemiology, and End Results (SEER) data. The timing of these improvements led to suggestions that they result from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramagopalan, Sreeram, Leahy, Thomas P., Ray, Joshua, Wilkinson, Samantha, Sammon, Cormac, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442434/
https://www.ncbi.nlm.nih.gov/pubmed/34521405
http://dx.doi.org/10.1186/s12916-021-02070-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442434/
https://www.ncbi.nlm.nih.gov/pubmed/34521405
http://dx.doi.org/10.1186/s12916-021-02070-w

Ejemplares similares